These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17123290)

  • 1. Model for end-stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding.
    Sheiner P; Gish RG; Sanyal A
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S112-3. PubMed ID: 17123290
    [No Abstract]   [Full Text] [Related]  

  • 2. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension.
    Krowka MJ; Fallon MB; Mulligan DC; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S114-6. PubMed ID: 17123283
    [No Abstract]   [Full Text] [Related]  

  • 3. Is there still a role for surgery in bleeding portal hypertension?
    Henderson JM; Yang Y
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):246-7. PubMed ID: 16265209
    [No Abstract]   [Full Text] [Related]  

  • 4. Model for end-stage liver disease (MELD) exception guidelines.
    Wiesner R; Lake JR; Freeman RB; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-7. PubMed ID: 17123285
    [No Abstract]   [Full Text] [Related]  

  • 5. Model for end-stage liver disease (MELD) exception for polycystic liver disease.
    Arrazola L; Moonka D; Gish RG; Everson GT
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S110-1. PubMed ID: 17123287
    [No Abstract]   [Full Text] [Related]  

  • 6. Model for end-stage liver disease (MELD) exception for severe pruritus.
    Washburn WK; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S119. PubMed ID: 17123292
    [No Abstract]   [Full Text] [Related]  

  • 7. Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.
    McDiarmid S; Gish RG; Horslen S; Mazariegos GV
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S124-7. PubMed ID: 17123278
    [No Abstract]   [Full Text] [Related]  

  • 8. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy.
    Ham J; Gish RG; Mullen K
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S102-4. PubMed ID: 17123294
    [No Abstract]   [Full Text] [Related]  

  • 9. Model for end-stage liver disease (MELD) exception for ascites.
    Biggins SW; Colquhoun S; Gish RG; Runyon BA
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S88-90. PubMed ID: 17123288
    [No Abstract]   [Full Text] [Related]  

  • 10. Model for end-stage liver disease (MELD) exception for cystic fibrosis.
    Horslen S; Sweet S; Gish RG; Shepherd R
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S98-9. PubMed ID: 17123272
    [No Abstract]   [Full Text] [Related]  

  • 11. Model for end-stage liver disease (MELD) exception for cholangiocarcinoma or biliary dysplasia.
    Gores GJ; Gish RG; Sudan D; Rosen CB;
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S95-7. PubMed ID: 17123289
    [No Abstract]   [Full Text] [Related]  

  • 12. Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome.
    Washburn WK; Gish RG; Kamath PS
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S93-4. PubMed ID: 17123293
    [No Abstract]   [Full Text] [Related]  

  • 13. Model for end-stage liver disease (MELD) exception for primary hyperoxaluria.
    Horslen S; Gish RG; McDonald R
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S117-8. PubMed ID: 17123291
    [No Abstract]   [Full Text] [Related]  

  • 14. Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia.
    Garcia-Tsao G; Gish RG; Punch J
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S108-9. PubMed ID: 17123286
    [No Abstract]   [Full Text] [Related]  

  • 15. Model for end-stage liver disease (MELD) exception small-for-size syndrome.
    Sheiner P; Belghiti J; Gish RG; Miller C
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S120-1. PubMed ID: 17123277
    [No Abstract]   [Full Text] [Related]  

  • 16. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
    Pomfret E; Gish RG; Brandhagen D
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
    [No Abstract]   [Full Text] [Related]  

  • 17. Model for end-stage liver disease (MELD) exception for bacterial cholangitis.
    Gores GJ; Gish RG; Shrestha R; Wiesner RH
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S91-2. PubMed ID: 17123280
    [No Abstract]   [Full Text] [Related]  

  • 18. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome.
    Fallon MB; Mulligan DC; Gish RG; Krowka MJ
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S105-7. PubMed ID: 17123282
    [No Abstract]   [Full Text] [Related]  

  • 19. Model for end-stage liver disease (MELD) exception for uncommon hepatic tumors.
    Punch J; Gish RG
    Liver Transpl; 2006 Dec; 12(12 Suppl 3):S122-3. PubMed ID: 17123279
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of transjugular intrahepatic portosystemic shunt (TIPS) in an 84 year-old patient during acute variceal bleeding].
    Grinberg AR; de la Serna F; Silva M; Finkielman JD; Magariños E; Festa HM; Lorenzino GA; Cazenave CA
    Medicina (B Aires); 1998; 58(3):295-7. PubMed ID: 9713100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.